PTPN11 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "PTPN11" in English language version.

Last modified: 17:06:32, 11 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

138106nih.gov

5^th place

10579doi.org

2^nd place

99adsabs.harvard.edu

14^th place

9^th place

98semanticscholar.org

15^th place

8^th place

62ensembl.org

630^th place

326^th place

31books.google.com

3^rd place

22hdl.handle.net

66^th place

34^th place

11worldcat.org

4^th place

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Freeman RM, Plutzky J, Neel BG (December 1992). "Identification of a human Src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew". Proceedings of the National Academy of Sciences of the United States of America. 89 (23): 11239–11243. Bibcode:1992PNAS...8911239F. doi:10.1073/pnas.89.23.11239. PMC 50525. PMID 1280823.
Bonetti M, Rodriguez-Martinez V, Paardekooper Overman J, Overvoorde J, van Eekelen M, Jopling C, et al. (15 April 2014). Roehl HH (ed.). "Distinct and overlapping functions of ptpn11 genes in Zebrafish development". PLOS ONE. 9 (4) e94884. Bibcode:2014PLoSO...994884B. doi:10.1371/journal.pone.0094884. PMC 3988099. PMID 24736444.
Šimčíková D, Heneberg P (December 2019). "Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases". Scientific Reports. 9 (1) 18577. Bibcode:2019NatSR...918577S. doi:10.1038/s41598-019-54976-4. PMC 6901466. PMID 31819097.
Pumphrey NJ, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, et al. (April 1999). "Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31". FEBS Letters. 450 (1–2): 77–83. Bibcode:1999FEBSL.450...77P. doi:10.1016/S0014-5793(99)00446-9. PMID 10350061. S2CID 31471121.
Crouin C, Arnaud M, Gesbert F, Camonis J, Bertoglio J (April 2001). "A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners". FEBS Letters. 495 (3): 148–153. Bibcode:2001FEBSL.495..148C. doi:10.1016/S0014-5793(01)02373-0. PMID 11334882. S2CID 24499468.
Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG (July 1994). "Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras". Proceedings of the National Academy of Sciences of the United States of America. 91 (15): 7335–7339. Bibcode:1994PNAS...91.7335B. doi:10.1073/pnas.91.15.7335. PMC 44394. PMID 8041791.
Maegawa H, Ugi S, Adachi M, Hinoda Y, Kikkawa R, Yachi A, et al. (March 1994). "Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro". Biochemical and Biophysical Research Communications. 199 (2): 780–785. Bibcode:1994BBRC..199..780M. doi:10.1006/bbrc.1994.1297. PMID 8135823.
Maegawa H, Kashiwagi A, Fujita T, Ugi S, Hasegawa M, Obata T, et al. (November 1996). "SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates". Biochemical and Biophysical Research Communications. 228 (1): 122–127. Bibcode:1996BBRC..228..122M. doi:10.1006/bbrc.1996.1626. PMID 8912646.
Chin H, Saito T, Arai A, Yamamoto K, Kamiyama R, Miyasaka N, et al. (October 1997). "Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells". Biochemical and Biophysical Research Communications. 239 (2): 412–417. Bibcode:1997BBRC..239..412C. doi:10.1006/bbrc.1997.7480. PMID 9344843.

books.google.com (Global: 3^rd place; English: 3^rd place)

Lai LA, Zhao C, Zhang EE, Feng GS (2004). "14 The Shp-2 tyrosine phosphatase". In Ariño J, Alexander D (eds.). Protein phosphatases. Springer. pp. 275–299. ISBN 978-3-540-20560-9.

doi.org (Global: 2^nd place; English: 2^nd place)

Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, et al. (December 1994). "Mapping a gene for Noonan syndrome to the long arm of chromosome 12". Nature Genetics. 8 (4): 357–360. doi:10.1038/ng1294-357. PMID 7894486. S2CID 1582162.
Freeman RM, Plutzky J, Neel BG (December 1992). "Identification of a human Src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew". Proceedings of the National Academy of Sciences of the United States of America. 89 (23): 11239–11243. Bibcode:1992PNAS...8911239F. doi:10.1073/pnas.89.23.11239. PMC 50525. PMID 1280823.
Kondo R, Kondo K, Nabeshima K, Nishikimi A, Ishida Y, Shigeoka T, et al. (28 May 2025). "PD-1 is conserved from sharks to humans: new insights into PD-1, PD-L1, PD-L2, and SHP-2 evolution". Frontiers in Immunology. 16 1573492. doi:10.3389/fimmu.2025.1573492. PMC 12151841. PMID 40503235.
Bonetti M, Rodriguez-Martinez V, Paardekooper Overman J, Overvoorde J, van Eekelen M, Jopling C, et al. (15 April 2014). Roehl HH (ed.). "Distinct and overlapping functions of ptpn11 genes in Zebrafish development". PLOS ONE. 9 (4) e94884. Bibcode:2014PLoSO...994884B. doi:10.1371/journal.pone.0094884. PMC 3988099. PMID 24736444.
Neel BG, Gu H, Pao L (June 2003). "The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling". Trends in Biochemical Sciences. 28 (6): 284–293. doi:10.1016/S0968-0004(03)00091-4. PMID 12826400.
Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, et al. (June 2003). "Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia". Nature Genetics. 34 (2): 148–150. doi:10.1038/ng1156. PMID 12717436.
Clandinin TR, DeModena JA, Sternberg PW (February 1998). "Inositol trisphosphate mediates a RAS-independent response to LET-23 receptor tyrosine kinase activation in C. elegans". Cell. 92 (4): 523–533. doi:10.1016/s0092-8674(00)80945-9. PMID 9491893.
Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. (December 2001). "Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome". Nature Genetics. 29 (4): 465–468. doi:10.1038/ng772. PMID 11704759.
Li SM (2016). "[The Biological Function of SHP2 in Human Disease]". Molekuliarnaia Biologiia (in Russian). 50 (1). Mosk: 27–33. doi:10.7868/S0026898416010110. PMID 27028808.
Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, et al. (February 2006). "Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease". American Journal of Human Genetics. 78 (2): 279–290. doi:10.1086/499925. PMC 1380235. PMID 16358218.
Hill KS, Roberts ER, Wang X, Marin E, Park TD, Son S, et al. (February 2019). "PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas". Molecular Cancer Research. 17 (2): 583–593. doi:10.1158/1541-7786.MCR-18-0777. PMC 6386183. PMID 30355677.
Šimčíková D, Heneberg P (December 2019). "Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases". Scientific Reports. 9 (1) 18577. Bibcode:2019NatSR...918577S. doi:10.1038/s41598-019-54976-4. PMC 6901466. PMID 31819097.
Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, et al. (June 2002). "PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity". American Journal of Human Genetics. 70 (6): 1555–1563. doi:10.1086/340847. PMC 379142. PMID 11992261.
Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, et al. (January 2007). "Germline gain-of-function mutations in SOS1 cause Noonan syndrome". Nature Genetics. 39 (1): 70–74. doi:10.1038/ng1926. PMID 17143285. S2CID 10222262.
Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG (March 2006). "PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects". The Journal of Biological Chemistry. 281 (10): 6785–6792. doi:10.1074/jbc.M513068200. PMID 16377799.
Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns JP (August 2002). "PTPN11 mutations in LEOPARD syndrome". Journal of Medical Genetics. 39 (8): 571–574. doi:10.1136/jmg.39.8.571. PMC 1735195. PMID 12161596.
Sobreira NL, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, Stevens EL, et al. (June 2010). "Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene". PLoS Genetics. 6 (6) e1000991. doi:10.1371/journal.pgen.1000991. PMC 2887469. PMID 20577567.
Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, et al. (December 2004). "Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia". Cancer Research. 64 (24): 8816–8820. doi:10.1158/0008-5472.CAN-04-1923. PMID 15604238.
Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP, et al. (May 2018). "High NPM1 mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML". Blood. 131 (25): 2816–2825. doi:10.1182/blood-2018-01-828467. PMC 6265642. PMID 29724895.
Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, Princen F, et al. (May 2011). "Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis". Cancer Cell. 19 (5): 629–639. doi:10.1016/j.ccr.2011.03.023. PMC 3098128. PMID 21575863.
Hatakeyama M, Higashi H (December 2005). "Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis". Cancer Science. 96 (12): 835–843. doi:10.1111/j.1349-7006.2005.00130.x. PMC 11159386. PMID 16367902. S2CID 5721063.
Hatakeyama M (September 2004). "Oncogenic mechanisms of the Helicobacter pylori CagA protein". Nature Reviews. Cancer. 4 (9): 688–694. doi:10.1038/nrc1433. PMID 15343275. S2CID 1218835.
Tanaka Y, Tanaka N, Saeki Y, Tanaka K, Murakami M, Hirano T, et al. (August 2008). "c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130". Molecular and Cellular Biology. 28 (15): 4805–4818. doi:10.1128/MCB.01784-07. PMC 2493370. PMID 18519587.
Tauchi T, Feng GS, Marshall MS, Shen R, Mantel C, Pawson T, et al. (October 1994). "The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells". The Journal of Biological Chemistry. 269 (40): 25206–25211. doi:10.1016/S0021-9258(17)31518-1. PMID 7523381.
Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, Siminovitch KA (April 1998). "SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain". Molecular and Cellular Biology. 18 (4): 2089–2099. doi:10.1128/MCB.18.4.2089. PMC 121439. PMID 9528781.
Ilan N, Cheung L, Pinter E, Madri JA (July 2000). "Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation". The Journal of Biological Chemistry. 275 (28): 21435–21443. doi:10.1074/jbc.M001857200. PMID 10801826.
Pumphrey NJ, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, et al. (April 1999). "Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31". FEBS Letters. 450 (1–2): 77–83. Bibcode:1999FEBSL.450...77P. doi:10.1016/S0014-5793(99)00446-9. PMID 10350061. S2CID 31471121.
Hua CT, Gamble JR, Vadas MA, Jackson DE (October 1998). "Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates". The Journal of Biological Chemistry. 273 (43): 28332–28340. doi:10.1074/jbc.273.43.28332. PMID 9774457.
Jackson DE, Ward CM, Wang R, Newman PJ (March 1997). "The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling". The Journal of Biological Chemistry. 272 (11): 6986–6993. doi:10.1074/jbc.272.11.6986. PMID 9054388.
Huber M, Izzi L, Grondin P, Houde C, Kunath T, Veillette A, et al. (January 1999). "The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells". The Journal of Biological Chemistry. 274 (1): 335–344. doi:10.1074/jbc.274.1.335. PMID 9867848.
Schulze WX, Deng L, Mann M (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Molecular Systems Biology. 1 (1): 2005.0008. doi:10.1038/msb4100012. PMC 1681463. PMID 16729043.
Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov E, Ullrich A, et al. (September 1995). "Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C". The Journal of Biological Chemistry. 270 (36): 21277–21284. doi:10.1074/jbc.270.36.21277. PMID 7673163.
Delahaye L, Rocchi S, Van Obberghen E (February 2000). "Potential involvement of FRS2 in insulin signaling". Endocrinology. 141 (2): 621–628. doi:10.1210/endo.141.2.7298. PMID 10650943.
Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M (April 2001). "Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction". Oncogene. 20 (16): 1929–1938. doi:10.1038/sj.onc.1204290. PMID 11360177. S2CID 25346661.
Hadari YR, Kouhara H, Lax I, Schlessinger J (July 1998). "Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation". Molecular and Cellular Biology. 18 (7): 3966–3973. doi:10.1128/MCB.18.7.3966. PMC 108981. PMID 9632781.
Saito Y, Hojo Y, Tanimoto T, Abe J, Berk BC (June 2002). "Protein kinase C-alpha and protein kinase C-epsilon are required for Grb2-associated binder-1 tyrosine phosphorylation in response to platelet-derived growth factor". The Journal of Biological Chemistry. 277 (26): 23216–23222. doi:10.1074/jbc.M200605200. PMID 11940581.
Rocchi S, Tartare-Deckert S, Murdaca J, Holgado-Madruga M, Wong AJ, Van Obberghen E (July 1998). "Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules". Molecular Endocrinology. 12 (7). Baltimore, Md.: 914–923. doi:10.1210/mend.12.7.0141. PMID 9658397.
Boudot C, Kadri Z, Petitfrère E, Lambert E, Chrétien S, Mayeux P, et al. (October 2002). "Phosphatidylinositol 3-kinase regulates glycosylphosphatidylinositol hydrolysis through PLC-gamma(2) activation in erythropoietin-stimulated cells". Cellular Signalling. 14 (10): 869–878. doi:10.1016/S0898-6568(02)00036-0. PMID 12135708.
Lynch DK, Daly RJ (January 2002). "PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2". The EMBO Journal. 21 (1–2): 72–82. doi:10.1093/emboj/21.1.72. PMC 125816. PMID 11782427.
Zhao C, Yu DH, Shen R, Feng GS (July 1999). "Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1". The Journal of Biological Chemistry. 274 (28): 19649–19654. doi:10.1074/jbc.274.28.19649. PMID 10391903.
Crouin C, Arnaud M, Gesbert F, Camonis J, Bertoglio J (April 2001). "A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners". FEBS Letters. 495 (3): 148–153. Bibcode:2001FEBSL.495..148C. doi:10.1016/S0014-5793(01)02373-0. PMID 11334882. S2CID 24499468.
Wolf I, Jenkins BJ, Liu Y, Seiffert M, Custodio JM, Young P, et al. (January 2002). "Gab3, a New DOS/Gab Family Member, Facilitates Macrophage Differentiation". Molecular and Cellular Biology. 22 (1): 231–244. doi:10.1128/MCB.22.1.231-244.2002. ISSN 0270-7306. PMC 134230. PMID 11739737. and associates transiently with the SH2 domain-containing proteins p85 and SHP2
Lehmann U, Schmitz J, Weissenbach M, Sobota RM, Hortner M, Friederichs K, et al. (January 2003). "SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130". The Journal of Biological Chemistry. 278 (1): 661–671. doi:10.1074/jbc.M210552200. PMID 12403768.
Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, et al. (September 2000). "Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation". Journal of Immunology. 165 (5). Baltimore, Md.: 2535–2543. doi:10.4049/jimmunol.165.5.2535. PMID 10946280.
Kim H, Baumann H (December 1997). "Transmembrane domain of gp130 contributes to intracellular signal transduction in hepatic cells". The Journal of Biological Chemistry. 272 (49): 30741–30747. doi:10.1074/jbc.272.49.30741. PMID 9388212.
Yin T, Shen R, Feng GS, Yang YC (January 1997). "Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases". The Journal of Biological Chemistry. 272 (2): 1032–1037. doi:10.1074/jbc.272.2.1032. PMID 8995399.
Ganju RK, Brubaker SA, Chernock RD, Avraham S, Groopman JE (June 2000). "Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk". The Journal of Biological Chemistry. 275 (23): 17263–17268. doi:10.1074/jbc.M000689200. PMID 10747947.
Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG (July 1994). "Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras". Proceedings of the National Academy of Sciences of the United States of America. 91 (15): 7335–7339. Bibcode:1994PNAS...91.7335B. doi:10.1073/pnas.91.15.7335. PMC 44394. PMID 8041791.
Ward AC, Monkhouse JL, Hamilton JA, Csar XF (November 1998). "Direct binding of Shc, Grb2, SHP-2 and p40 to the murine granulocyte colony-stimulating factor receptor". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1448 (1): 70–76. doi:10.1016/S0167-4889(98)00120-7. hdl:10536/DRO/DU:30096477. PMID 9824671.
Tang J, Feng GS, Li W (October 1997). "Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor". Oncogene. 15 (15): 1823–1832. doi:10.1038/sj.onc.1201351. PMID 9362449.
Tang H, Zhao ZJ, Huang XY, Landon EJ, Inagami T (April 1999). "Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells". The Journal of Biological Chemistry. 274 (18): 12401–12407. doi:10.1074/jbc.274.18.12401. PMID 10212213.
Zhang S, Mantel C, Broxmeyer HE (March 1999). "Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells". Journal of Leukocyte Biology. 65 (3): 372–380. doi:10.1002/jlb.65.3.372. PMID 10080542. S2CID 38211235.
Wong L, Johnson GR (August 1996). "Epidermal growth factor induces coupling of protein-tyrosine phosphatase 1D to GRB2 via the COOH-terminal SH3 domain of GRB2". The Journal of Biological Chemistry. 271 (35): 20981–20984. doi:10.1074/jbc.271.35.20981. PMID 8702859.
Stofega MR, Herrington J, Billestrup N, Carter-Su C (September 2000). "Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B". Molecular Endocrinology. 14 (9). Baltimore, Md.: 1338–1350. doi:10.1210/mend.14.9.0513. PMID 10976913.
Moutoussamy S, Renaudie F, Lago F, Kelly PA, Finidori J (June 1998). "Grb10 identified as a potential regulator of growth hormone (GH) signaling by cloning of GH receptor target proteins". The Journal of Biological Chemistry. 273 (26): 15906–15912. doi:10.1074/jbc.273.26.15906. PMID 9632636.
Wang H, Lindsey S, Konieczna I, Bei L, Horvath E, Huang W, et al. (January 2009). "Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia". The Journal of Biological Chemistry. 284 (4): 2549–2567. doi:10.1074/jbc.M804704200. PMC 2629090. PMID 19022774.
Maegawa H, Ugi S, Adachi M, Hinoda Y, Kikkawa R, Yachi A, et al. (March 1994). "Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro". Biochemical and Biophysical Research Communications. 199 (2): 780–785. Bibcode:1994BBRC..199..780M. doi:10.1006/bbrc.1994.1297. PMID 8135823.
Kharitonenkov A, Schnekenburger J, Chen Z, Knyazev P, Ali S, Zwick E, et al. (December 1995). "Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction". The Journal of Biological Chemistry. 270 (49): 29189–29193. doi:10.1074/jbc.270.49.29189. PMID 7493946.
Mañes S, Mira E, Gómez-Mouton C, Zhao ZJ, Lacalle RA, Martínez-A C (April 1999). "Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility". Molecular and Cellular Biology. 19 (4): 3125–3135. doi:10.1128/mcb.19.4.3125. PMC 84106. PMID 10082579.
Seely BL, Reichart DR, Staubs PA, Jhun BH, Hsu D, Maegawa H, et al. (August 1995). "Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein". The Journal of Biological Chemistry. 270 (32): 19151–19157. doi:10.1074/jbc.270.32.19151. PMID 7642582.
Kuhné MR, Pawson T, Lienhard GE, Feng GS (June 1993). "The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp". The Journal of Biological Chemistry. 268 (16): 11479–11481. doi:10.1016/S0021-9258(19)50220-4. PMID 8505282.
Myers MG, Mendez R, Shi P, Pierce JH, Rhoads R, White MF (October 1998). "The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling". The Journal of Biological Chemistry. 273 (41): 26908–26914. doi:10.1074/jbc.273.41.26908. PMID 9756938.
Tauchi T, Damen JE, Toyama K, Feng GS, Broxmeyer HE, Krystal G (June 1996). "Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis". Blood. 87 (11): 4495–4501. doi:10.1182/blood.V87.11.4495.bloodjournal87114495. PMID 8639815.
Maegawa H, Kashiwagi A, Fujita T, Ugi S, Hasegawa M, Obata T, et al. (November 1996). "SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates". Biochemical and Biophysical Research Communications. 228 (1): 122–127. Bibcode:1996BBRC..228..122M. doi:10.1006/bbrc.1996.1626. PMID 8912646.
Fournier N, Chalus L, Durand I, Garcia E, Pin JJ, Churakova T, et al. (August 2000). "FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells". Journal of Immunology. 165 (3). Baltimore, Md.: 1197–1209. doi:10.4049/jimmunol.165.3.1197. PMID 10903717.
Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, et al. (August 1997). "LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes". Immunity. 7 (2): 283–290. doi:10.1016/S1074-7613(00)80530-0. hdl:2066/26173. PMID 9285412.
Betts GN, van der Geer P, Komives EA (June 2008). "Structural and functional consequences of tyrosine phosphorylation in the LRP1 cytoplasmic domain". The Journal of Biological Chemistry. 283 (23): 15656–15664. doi:10.1074/jbc.M709514200. PMC 2414285. PMID 18381291.
Keilhack H, Müller M, Böhmer SA, Frank C, Weidner KM, Birchmeier W, et al. (January 2001). "Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1". The Journal of Cell Biology. 152 (2): 325–334. doi:10.1083/jcb.152.2.325. PMC 2199605. PMID 11266449.
Lechleider RJ, Sugimoto S, Bennett AM, Kashishian AS, Cooper JA, Shoelson SE, et al. (October 1993). "Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor". The Journal of Biological Chemistry. 268 (29): 21478–21481. doi:10.1016/S0021-9258(20)80562-6. PMID 7691811.
Chauhan D, Pandey P, Hideshima T, Treon S, Raje N, Davies FE, et al. (September 2000). "SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells". The Journal of Biological Chemistry. 275 (36): 27845–27850. doi:10.1074/jbc.M003428200. PMID 10880513.
Howie D, Simarro M, Sayos J, Guirado M, Sancho J, Terhorst C (February 2000). "Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation". Blood. 99 (3): 957–965. doi:10.1182/blood.V99.3.957. PMID 11806999.
Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, et al. (November 2001). "Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells". The EMBO Journal. 20 (21): 5840–5852. doi:10.1093/emboj/20.21.5840. PMC 125701. PMID 11689425.
Chin H, Saito T, Arai A, Yamamoto K, Kamiyama R, Miyasaka N, et al. (October 1997). "Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells". Biochemical and Biophysical Research Communications. 239 (2): 412–417. Bibcode:1997BBRC..239..412C. doi:10.1006/bbrc.1997.7480. PMID 9344843.
Yu CL, Jin YJ, Burakoff SJ (January 2000). "Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation". The Journal of Biological Chemistry. 275 (1): 599–604. doi:10.1074/jbc.275.1.599. PMID 10617656.
Chughtai N, Schimchowitsch S, Lebrun JJ, Ali S (August 2002). "Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells". The Journal of Biological Chemistry. 277 (34): 31107–31114. doi:10.1074/jbc.M200156200. PMID 12060651.
Guo W, Xu Q (November 2020). "Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds". Journal of Pharmacological Sciences. 144 (3): 139–146. doi:10.1016/j.jphs.2020.06.002. PMID 32921395.
Kang D, Wang Y, Lin Y, Ma WW, Morgensztern D, Leventakos K, et al. (15 July 2025). "JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies". Clinical Cancer Research. 31 (14): 3019–3032. doi:10.1158/1078-0432.CCR-24-3691. PMID 40333694.
Luo J, Villaruz LC (February 2026). "Combined SHP2 and KRAS^G12C inhibitor therapy in patients with non-small-cell lung cancer". The Lancet. Respiratory Medicine. 14 (2): 107–109. doi:10.1016/S2213-2600(25)00298-X. PMID 41325754.
Song H, Zou X, Liang J, Huang H, Liu Y, Zhang Y, et al. (5 November 2025). "Discovery of SA-8 as a potent SHP2-AUTAC degrader in cancer therapy". European Journal of Medicinal Chemistry. 297 117918. doi:10.1016/j.ejmech.2025.117918. PMID 40609222.

ensembl.org (Global: 630^th place; English: 326^th place)

may2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000179295 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000043733 – Ensembl, May 2017

hdl.handle.net (Global: 66^th place; English: 34^th place)

Ward AC, Monkhouse JL, Hamilton JA, Csar XF (November 1998). "Direct binding of Shc, Grb2, SHP-2 and p40 to the murine granulocyte colony-stimulating factor receptor". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1448 (1): 70–76. doi:10.1016/S0167-4889(98)00120-7. hdl:10536/DRO/DU:30096477. PMID 9824671.
Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, et al. (August 1997). "LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes". Immunity. 7 (2): 283–290. doi:10.1016/S1074-7613(00)80530-0. hdl:2066/26173. PMID 9285412.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, et al. (December 1994). "Mapping a gene for Noonan syndrome to the long arm of chromosome 12". Nature Genetics. 8 (4): 357–360. doi:10.1038/ng1294-357. PMID 7894486. S2CID 1582162.
Freeman RM, Plutzky J, Neel BG (December 1992). "Identification of a human Src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew". Proceedings of the National Academy of Sciences of the United States of America. 89 (23): 11239–11243. Bibcode:1992PNAS...8911239F. doi:10.1073/pnas.89.23.11239. PMC 50525. PMID 1280823.
Kondo R, Kondo K, Nabeshima K, Nishikimi A, Ishida Y, Shigeoka T, et al. (28 May 2025). "PD-1 is conserved from sharks to humans: new insights into PD-1, PD-L1, PD-L2, and SHP-2 evolution". Frontiers in Immunology. 16 1573492. doi:10.3389/fimmu.2025.1573492. PMC 12151841. PMID 40503235.
Bonetti M, Rodriguez-Martinez V, Paardekooper Overman J, Overvoorde J, van Eekelen M, Jopling C, et al. (15 April 2014). Roehl HH (ed.). "Distinct and overlapping functions of ptpn11 genes in Zebrafish development". PLOS ONE. 9 (4) e94884. Bibcode:2014PLoSO...994884B. doi:10.1371/journal.pone.0094884. PMC 3988099. PMID 24736444.
Neel BG, Gu H, Pao L (June 2003). "The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling". Trends in Biochemical Sciences. 28 (6): 284–293. doi:10.1016/S0968-0004(03)00091-4. PMID 12826400.
Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, et al. (June 2003). "Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia". Nature Genetics. 34 (2): 148–150. doi:10.1038/ng1156. PMID 12717436.
Clandinin TR, DeModena JA, Sternberg PW (February 1998). "Inositol trisphosphate mediates a RAS-independent response to LET-23 receptor tyrosine kinase activation in C. elegans". Cell. 92 (4): 523–533. doi:10.1016/s0092-8674(00)80945-9. PMID 9491893.
Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. (December 2001). "Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome". Nature Genetics. 29 (4): 465–468. doi:10.1038/ng772. PMID 11704759.
Li SM (2016). "[The Biological Function of SHP2 in Human Disease]". Molekuliarnaia Biologiia (in Russian). 50 (1). Mosk: 27–33. doi:10.7868/S0026898416010110. PMID 27028808.
Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, et al. (February 2006). "Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease". American Journal of Human Genetics. 78 (2): 279–290. doi:10.1086/499925. PMC 1380235. PMID 16358218.
Hill KS, Roberts ER, Wang X, Marin E, Park TD, Son S, et al. (February 2019). "PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas". Molecular Cancer Research. 17 (2): 583–593. doi:10.1158/1541-7786.MCR-18-0777. PMC 6386183. PMID 30355677.
Šimčíková D, Heneberg P (December 2019). "Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases". Scientific Reports. 9 (1) 18577. Bibcode:2019NatSR...918577S. doi:10.1038/s41598-019-54976-4. PMC 6901466. PMID 31819097.
Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, et al. (June 2002). "PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity". American Journal of Human Genetics. 70 (6): 1555–1563. doi:10.1086/340847. PMC 379142. PMID 11992261.
Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, et al. (January 2007). "Germline gain-of-function mutations in SOS1 cause Noonan syndrome". Nature Genetics. 39 (1): 70–74. doi:10.1038/ng1926. PMID 17143285. S2CID 10222262.
Kontaridis MI, Swanson KD, David FS, Barford D, Neel BG (March 2006). "PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects". The Journal of Biological Chemistry. 281 (10): 6785–6792. doi:10.1074/jbc.M513068200. PMID 16377799.
Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns JP (August 2002). "PTPN11 mutations in LEOPARD syndrome". Journal of Medical Genetics. 39 (8): 571–574. doi:10.1136/jmg.39.8.571. PMC 1735195. PMID 12161596.
Sobreira NL, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, Stevens EL, et al. (June 2010). "Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene". PLoS Genetics. 6 (6) e1000991. doi:10.1371/journal.pgen.1000991. PMC 2887469. PMID 20577567.
Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, et al. (December 2004). "Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia". Cancer Research. 64 (24): 8816–8820. doi:10.1158/0008-5472.CAN-04-1923. PMID 15604238.
Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP, et al. (May 2018). "High NPM1 mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML". Blood. 131 (25): 2816–2825. doi:10.1182/blood-2018-01-828467. PMC 6265642. PMID 29724895.
Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, Princen F, et al. (May 2011). "Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis". Cancer Cell. 19 (5): 629–639. doi:10.1016/j.ccr.2011.03.023. PMC 3098128. PMID 21575863.
Hatakeyama M, Higashi H (December 2005). "Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis". Cancer Science. 96 (12): 835–843. doi:10.1111/j.1349-7006.2005.00130.x. PMC 11159386. PMID 16367902. S2CID 5721063.
Hatakeyama M (September 2004). "Oncogenic mechanisms of the Helicobacter pylori CagA protein". Nature Reviews. Cancer. 4 (9): 688–694. doi:10.1038/nrc1433. PMID 15343275. S2CID 1218835.
Tanaka Y, Tanaka N, Saeki Y, Tanaka K, Murakami M, Hirano T, et al. (August 2008). "c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130". Molecular and Cellular Biology. 28 (15): 4805–4818. doi:10.1128/MCB.01784-07. PMC 2493370. PMID 18519587.
Tauchi T, Feng GS, Marshall MS, Shen R, Mantel C, Pawson T, et al. (October 1994). "The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells". The Journal of Biological Chemistry. 269 (40): 25206–25211. doi:10.1016/S0021-9258(17)31518-1. PMID 7523381.
Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, Siminovitch KA (April 1998). "SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain". Molecular and Cellular Biology. 18 (4): 2089–2099. doi:10.1128/MCB.18.4.2089. PMC 121439. PMID 9528781.
Ilan N, Cheung L, Pinter E, Madri JA (July 2000). "Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation". The Journal of Biological Chemistry. 275 (28): 21435–21443. doi:10.1074/jbc.M001857200. PMID 10801826.
Pumphrey NJ, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, et al. (April 1999). "Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31". FEBS Letters. 450 (1–2): 77–83. Bibcode:1999FEBSL.450...77P. doi:10.1016/S0014-5793(99)00446-9. PMID 10350061. S2CID 31471121.
Hua CT, Gamble JR, Vadas MA, Jackson DE (October 1998). "Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates". The Journal of Biological Chemistry. 273 (43): 28332–28340. doi:10.1074/jbc.273.43.28332. PMID 9774457.
Jackson DE, Ward CM, Wang R, Newman PJ (March 1997). "The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling". The Journal of Biological Chemistry. 272 (11): 6986–6993. doi:10.1074/jbc.272.11.6986. PMID 9054388.
Huber M, Izzi L, Grondin P, Houde C, Kunath T, Veillette A, et al. (January 1999). "The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells". The Journal of Biological Chemistry. 274 (1): 335–344. doi:10.1074/jbc.274.1.335. PMID 9867848.
Schulze WX, Deng L, Mann M (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Molecular Systems Biology. 1 (1): 2005.0008. doi:10.1038/msb4100012. PMC 1681463. PMID 16729043.
Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov E, Ullrich A, et al. (September 1995). "Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C". The Journal of Biological Chemistry. 270 (36): 21277–21284. doi:10.1074/jbc.270.36.21277. PMID 7673163.
Delahaye L, Rocchi S, Van Obberghen E (February 2000). "Potential involvement of FRS2 in insulin signaling". Endocrinology. 141 (2): 621–628. doi:10.1210/endo.141.2.7298. PMID 10650943.
Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M (April 2001). "Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction". Oncogene. 20 (16): 1929–1938. doi:10.1038/sj.onc.1204290. PMID 11360177. S2CID 25346661.
Hadari YR, Kouhara H, Lax I, Schlessinger J (July 1998). "Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation". Molecular and Cellular Biology. 18 (7): 3966–3973. doi:10.1128/MCB.18.7.3966. PMC 108981. PMID 9632781.
Saito Y, Hojo Y, Tanimoto T, Abe J, Berk BC (June 2002). "Protein kinase C-alpha and protein kinase C-epsilon are required for Grb2-associated binder-1 tyrosine phosphorylation in response to platelet-derived growth factor". The Journal of Biological Chemistry. 277 (26): 23216–23222. doi:10.1074/jbc.M200605200. PMID 11940581.
Rocchi S, Tartare-Deckert S, Murdaca J, Holgado-Madruga M, Wong AJ, Van Obberghen E (July 1998). "Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules". Molecular Endocrinology. 12 (7). Baltimore, Md.: 914–923. doi:10.1210/mend.12.7.0141. PMID 9658397.
Boudot C, Kadri Z, Petitfrère E, Lambert E, Chrétien S, Mayeux P, et al. (October 2002). "Phosphatidylinositol 3-kinase regulates glycosylphosphatidylinositol hydrolysis through PLC-gamma(2) activation in erythropoietin-stimulated cells". Cellular Signalling. 14 (10): 869–878. doi:10.1016/S0898-6568(02)00036-0. PMID 12135708.
Lynch DK, Daly RJ (January 2002). "PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2". The EMBO Journal. 21 (1–2): 72–82. doi:10.1093/emboj/21.1.72. PMC 125816. PMID 11782427.
Zhao C, Yu DH, Shen R, Feng GS (July 1999). "Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1". The Journal of Biological Chemistry. 274 (28): 19649–19654. doi:10.1074/jbc.274.28.19649. PMID 10391903.
Crouin C, Arnaud M, Gesbert F, Camonis J, Bertoglio J (April 2001). "A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners". FEBS Letters. 495 (3): 148–153. Bibcode:2001FEBSL.495..148C. doi:10.1016/S0014-5793(01)02373-0. PMID 11334882. S2CID 24499468.
Wolf I, Jenkins BJ, Liu Y, Seiffert M, Custodio JM, Young P, et al. (January 2002). "Gab3, a New DOS/Gab Family Member, Facilitates Macrophage Differentiation". Molecular and Cellular Biology. 22 (1): 231–244. doi:10.1128/MCB.22.1.231-244.2002. ISSN 0270-7306. PMC 134230. PMID 11739737. and associates transiently with the SH2 domain-containing proteins p85 and SHP2
Lehmann U, Schmitz J, Weissenbach M, Sobota RM, Hortner M, Friederichs K, et al. (January 2003). "SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130". The Journal of Biological Chemistry. 278 (1): 661–671. doi:10.1074/jbc.M210552200. PMID 12403768.
Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, et al. (September 2000). "Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation". Journal of Immunology. 165 (5). Baltimore, Md.: 2535–2543. doi:10.4049/jimmunol.165.5.2535. PMID 10946280.
Kim H, Baumann H (December 1997). "Transmembrane domain of gp130 contributes to intracellular signal transduction in hepatic cells". The Journal of Biological Chemistry. 272 (49): 30741–30747. doi:10.1074/jbc.272.49.30741. PMID 9388212.
Yin T, Shen R, Feng GS, Yang YC (January 1997). "Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases". The Journal of Biological Chemistry. 272 (2): 1032–1037. doi:10.1074/jbc.272.2.1032. PMID 8995399.
Ganju RK, Brubaker SA, Chernock RD, Avraham S, Groopman JE (June 2000). "Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk". The Journal of Biological Chemistry. 275 (23): 17263–17268. doi:10.1074/jbc.M000689200. PMID 10747947.
Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG (July 1994). "Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras". Proceedings of the National Academy of Sciences of the United States of America. 91 (15): 7335–7339. Bibcode:1994PNAS...91.7335B. doi:10.1073/pnas.91.15.7335. PMC 44394. PMID 8041791.
Ward AC, Monkhouse JL, Hamilton JA, Csar XF (November 1998). "Direct binding of Shc, Grb2, SHP-2 and p40 to the murine granulocyte colony-stimulating factor receptor". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1448 (1): 70–76. doi:10.1016/S0167-4889(98)00120-7. hdl:10536/DRO/DU:30096477. PMID 9824671.
Tang J, Feng GS, Li W (October 1997). "Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor". Oncogene. 15 (15): 1823–1832. doi:10.1038/sj.onc.1201351. PMID 9362449.
Tang H, Zhao ZJ, Huang XY, Landon EJ, Inagami T (April 1999). "Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells". The Journal of Biological Chemistry. 274 (18): 12401–12407. doi:10.1074/jbc.274.18.12401. PMID 10212213.
Zhang S, Mantel C, Broxmeyer HE (March 1999). "Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells". Journal of Leukocyte Biology. 65 (3): 372–380. doi:10.1002/jlb.65.3.372. PMID 10080542. S2CID 38211235.
Wong L, Johnson GR (August 1996). "Epidermal growth factor induces coupling of protein-tyrosine phosphatase 1D to GRB2 via the COOH-terminal SH3 domain of GRB2". The Journal of Biological Chemistry. 271 (35): 20981–20984. doi:10.1074/jbc.271.35.20981. PMID 8702859.
Stofega MR, Herrington J, Billestrup N, Carter-Su C (September 2000). "Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B". Molecular Endocrinology. 14 (9). Baltimore, Md.: 1338–1350. doi:10.1210/mend.14.9.0513. PMID 10976913.
Moutoussamy S, Renaudie F, Lago F, Kelly PA, Finidori J (June 1998). "Grb10 identified as a potential regulator of growth hormone (GH) signaling by cloning of GH receptor target proteins". The Journal of Biological Chemistry. 273 (26): 15906–15912. doi:10.1074/jbc.273.26.15906. PMID 9632636.
Wang H, Lindsey S, Konieczna I, Bei L, Horvath E, Huang W, et al. (January 2009). "Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia". The Journal of Biological Chemistry. 284 (4): 2549–2567. doi:10.1074/jbc.M804704200. PMC 2629090. PMID 19022774.
Maegawa H, Ugi S, Adachi M, Hinoda Y, Kikkawa R, Yachi A, et al. (March 1994). "Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro". Biochemical and Biophysical Research Communications. 199 (2): 780–785. Bibcode:1994BBRC..199..780M. doi:10.1006/bbrc.1994.1297. PMID 8135823.
Kharitonenkov A, Schnekenburger J, Chen Z, Knyazev P, Ali S, Zwick E, et al. (December 1995). "Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction". The Journal of Biological Chemistry. 270 (49): 29189–29193. doi:10.1074/jbc.270.49.29189. PMID 7493946.
Mañes S, Mira E, Gómez-Mouton C, Zhao ZJ, Lacalle RA, Martínez-A C (April 1999). "Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility". Molecular and Cellular Biology. 19 (4): 3125–3135. doi:10.1128/mcb.19.4.3125. PMC 84106. PMID 10082579.
Seely BL, Reichart DR, Staubs PA, Jhun BH, Hsu D, Maegawa H, et al. (August 1995). "Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein". The Journal of Biological Chemistry. 270 (32): 19151–19157. doi:10.1074/jbc.270.32.19151. PMID 7642582.
Kuhné MR, Pawson T, Lienhard GE, Feng GS (June 1993). "The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp". The Journal of Biological Chemistry. 268 (16): 11479–11481. doi:10.1016/S0021-9258(19)50220-4. PMID 8505282.
Myers MG, Mendez R, Shi P, Pierce JH, Rhoads R, White MF (October 1998). "The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling". The Journal of Biological Chemistry. 273 (41): 26908–26914. doi:10.1074/jbc.273.41.26908. PMID 9756938.
Tauchi T, Damen JE, Toyama K, Feng GS, Broxmeyer HE, Krystal G (June 1996). "Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis". Blood. 87 (11): 4495–4501. doi:10.1182/blood.V87.11.4495.bloodjournal87114495. PMID 8639815.
Maegawa H, Kashiwagi A, Fujita T, Ugi S, Hasegawa M, Obata T, et al. (November 1996). "SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates". Biochemical and Biophysical Research Communications. 228 (1): 122–127. Bibcode:1996BBRC..228..122M. doi:10.1006/bbrc.1996.1626. PMID 8912646.
Fournier N, Chalus L, Durand I, Garcia E, Pin JJ, Churakova T, et al. (August 2000). "FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells". Journal of Immunology. 165 (3). Baltimore, Md.: 1197–1209. doi:10.4049/jimmunol.165.3.1197. PMID 10903717.
Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, et al. (August 1997). "LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes". Immunity. 7 (2): 283–290. doi:10.1016/S1074-7613(00)80530-0. hdl:2066/26173. PMID 9285412.
Betts GN, van der Geer P, Komives EA (June 2008). "Structural and functional consequences of tyrosine phosphorylation in the LRP1 cytoplasmic domain". The Journal of Biological Chemistry. 283 (23): 15656–15664. doi:10.1074/jbc.M709514200. PMC 2414285. PMID 18381291.
Keilhack H, Müller M, Böhmer SA, Frank C, Weidner KM, Birchmeier W, et al. (January 2001). "Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1". The Journal of Cell Biology. 152 (2): 325–334. doi:10.1083/jcb.152.2.325. PMC 2199605. PMID 11266449.
Lechleider RJ, Sugimoto S, Bennett AM, Kashishian AS, Cooper JA, Shoelson SE, et al. (October 1993). "Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor". The Journal of Biological Chemistry. 268 (29): 21478–21481. doi:10.1016/S0021-9258(20)80562-6. PMID 7691811.
Chauhan D, Pandey P, Hideshima T, Treon S, Raje N, Davies FE, et al. (September 2000). "SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells". The Journal of Biological Chemistry. 275 (36): 27845–27850. doi:10.1074/jbc.M003428200. PMID 10880513.
Howie D, Simarro M, Sayos J, Guirado M, Sancho J, Terhorst C (February 2000). "Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation". Blood. 99 (3): 957–965. doi:10.1182/blood.V99.3.957. PMID 11806999.
Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, et al. (November 2001). "Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells". The EMBO Journal. 20 (21): 5840–5852. doi:10.1093/emboj/20.21.5840. PMC 125701. PMID 11689425.
Chin H, Saito T, Arai A, Yamamoto K, Kamiyama R, Miyasaka N, et al. (October 1997). "Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells". Biochemical and Biophysical Research Communications. 239 (2): 412–417. Bibcode:1997BBRC..239..412C. doi:10.1006/bbrc.1997.7480. PMID 9344843.
Yu CL, Jin YJ, Burakoff SJ (January 2000). "Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation". The Journal of Biological Chemistry. 275 (1): 599–604. doi:10.1074/jbc.275.1.599. PMID 10617656.
Chughtai N, Schimchowitsch S, Lebrun JJ, Ali S (August 2002). "Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells". The Journal of Biological Chemistry. 277 (34): 31107–31114. doi:10.1074/jbc.M200156200. PMID 12060651.
Guo W, Xu Q (November 2020). "Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds". Journal of Pharmacological Sciences. 144 (3): 139–146. doi:10.1016/j.jphs.2020.06.002. PMID 32921395.
Kang D, Wang Y, Lin Y, Ma WW, Morgensztern D, Leventakos K, et al. (15 July 2025). "JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies". Clinical Cancer Research. 31 (14): 3019–3032. doi:10.1158/1078-0432.CCR-24-3691. PMID 40333694.
Luo J, Villaruz LC (February 2026). "Combined SHP2 and KRAS^G12C inhibitor therapy in patients with non-small-cell lung cancer". The Lancet. Respiratory Medicine. 14 (2): 107–109. doi:10.1016/S2213-2600(25)00298-X. PMID 41325754.
Song H, Zou X, Liang J, Huang H, Liu Y, Zhang Y, et al. (5 November 2025). "Discovery of SA-8 as a potent SHP2-AUTAC degrader in cancer therapy". European Journal of Medicinal Chemistry. 297 117918. doi:10.1016/j.ejmech.2025.117918. PMID 40609222.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Freeman RM, Plutzky J, Neel BG (December 1992). "Identification of a human Src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew". Proceedings of the National Academy of Sciences of the United States of America. 89 (23): 11239–11243. Bibcode:1992PNAS...8911239F. doi:10.1073/pnas.89.23.11239. PMC 50525. PMID 1280823.
"Entrez Gene: PTPN11 protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1)".
Kondo R, Kondo K, Nabeshima K, Nishikimi A, Ishida Y, Shigeoka T, et al. (28 May 2025). "PD-1 is conserved from sharks to humans: new insights into PD-1, PD-L1, PD-L2, and SHP-2 evolution". Frontiers in Immunology. 16 1573492. doi:10.3389/fimmu.2025.1573492. PMC 12151841. PMID 40503235.
Bonetti M, Rodriguez-Martinez V, Paardekooper Overman J, Overvoorde J, van Eekelen M, Jopling C, et al. (15 April 2014). Roehl HH (ed.). "Distinct and overlapping functions of ptpn11 genes in Zebrafish development". PLOS ONE. 9 (4) e94884. Bibcode:2014PLoSO...994884B. doi:10.1371/journal.pone.0094884. PMC 3988099. PMID 24736444.
Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, et al. (February 2006). "Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease". American Journal of Human Genetics. 78 (2): 279–290. doi:10.1086/499925. PMC 1380235. PMID 16358218.
Hill KS, Roberts ER, Wang X, Marin E, Park TD, Son S, et al. (February 2019). "PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas". Molecular Cancer Research. 17 (2): 583–593. doi:10.1158/1541-7786.MCR-18-0777. PMC 6386183. PMID 30355677.
Šimčíková D, Heneberg P (December 2019). "Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases". Scientific Reports. 9 (1) 18577. Bibcode:2019NatSR...918577S. doi:10.1038/s41598-019-54976-4. PMC 6901466. PMID 31819097.
Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, et al. (June 2002). "PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity". American Journal of Human Genetics. 70 (6): 1555–1563. doi:10.1086/340847. PMC 379142. PMID 11992261.
Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns JP (August 2002). "PTPN11 mutations in LEOPARD syndrome". Journal of Medical Genetics. 39 (8): 571–574. doi:10.1136/jmg.39.8.571. PMC 1735195. PMID 12161596.
Sobreira NL, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, Stevens EL, et al. (June 2010). "Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene". PLoS Genetics. 6 (6) e1000991. doi:10.1371/journal.pgen.1000991. PMC 2887469. PMID 20577567.
Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP, et al. (May 2018). "High NPM1 mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML". Blood. 131 (25): 2816–2825. doi:10.1182/blood-2018-01-828467. PMC 6265642. PMID 29724895.
Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, Princen F, et al. (May 2011). "Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis". Cancer Cell. 19 (5): 629–639. doi:10.1016/j.ccr.2011.03.023. PMC 3098128. PMID 21575863.
Hatakeyama M, Higashi H (December 2005). "Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis". Cancer Science. 96 (12): 835–843. doi:10.1111/j.1349-7006.2005.00130.x. PMC 11159386. PMID 16367902. S2CID 5721063.
Tanaka Y, Tanaka N, Saeki Y, Tanaka K, Murakami M, Hirano T, et al. (August 2008). "c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130". Molecular and Cellular Biology. 28 (15): 4805–4818. doi:10.1128/MCB.01784-07. PMC 2493370. PMID 18519587.
Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, Siminovitch KA (April 1998). "SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain". Molecular and Cellular Biology. 18 (4): 2089–2099. doi:10.1128/MCB.18.4.2089. PMC 121439. PMID 9528781.
Schulze WX, Deng L, Mann M (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family". Molecular Systems Biology. 1 (1): 2005.0008. doi:10.1038/msb4100012. PMC 1681463. PMID 16729043.
Hadari YR, Kouhara H, Lax I, Schlessinger J (July 1998). "Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation". Molecular and Cellular Biology. 18 (7): 3966–3973. doi:10.1128/MCB.18.7.3966. PMC 108981. PMID 9632781.
Lynch DK, Daly RJ (January 2002). "PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2". The EMBO Journal. 21 (1–2): 72–82. doi:10.1093/emboj/21.1.72. PMC 125816. PMID 11782427.
Wolf I, Jenkins BJ, Liu Y, Seiffert M, Custodio JM, Young P, et al. (January 2002). "Gab3, a New DOS/Gab Family Member, Facilitates Macrophage Differentiation". Molecular and Cellular Biology. 22 (1): 231–244. doi:10.1128/MCB.22.1.231-244.2002. ISSN 0270-7306. PMC 134230. PMID 11739737. and associates transiently with the SH2 domain-containing proteins p85 and SHP2
Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG (July 1994). "Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras". Proceedings of the National Academy of Sciences of the United States of America. 91 (15): 7335–7339. Bibcode:1994PNAS...91.7335B. doi:10.1073/pnas.91.15.7335. PMC 44394. PMID 8041791.
Wang H, Lindsey S, Konieczna I, Bei L, Horvath E, Huang W, et al. (January 2009). "Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia". The Journal of Biological Chemistry. 284 (4): 2549–2567. doi:10.1074/jbc.M804704200. PMC 2629090. PMID 19022774.
Mañes S, Mira E, Gómez-Mouton C, Zhao ZJ, Lacalle RA, Martínez-A C (April 1999). "Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility". Molecular and Cellular Biology. 19 (4): 3125–3135. doi:10.1128/mcb.19.4.3125. PMC 84106. PMID 10082579.
Betts GN, van der Geer P, Komives EA (June 2008). "Structural and functional consequences of tyrosine phosphorylation in the LRP1 cytoplasmic domain". The Journal of Biological Chemistry. 283 (23): 15656–15664. doi:10.1074/jbc.M709514200. PMC 2414285. PMID 18381291.
Keilhack H, Müller M, Böhmer SA, Frank C, Weidner KM, Birchmeier W, et al. (January 2001). "Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1". The Journal of Cell Biology. 152 (2): 325–334. doi:10.1083/jcb.152.2.325. PMC 2199605. PMID 11266449.
Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, et al. (November 2001). "Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells". The EMBO Journal. 20 (21): 5840–5852. doi:10.1093/emboj/20.21.5840. PMC 125701. PMID 11689425.

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, et al. (December 1994). "Mapping a gene for Noonan syndrome to the long arm of chromosome 12". Nature Genetics. 8 (4): 357–360. doi:10.1038/ng1294-357. PMID 7894486. S2CID 1582162.
Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, et al. (January 2007). "Germline gain-of-function mutations in SOS1 cause Noonan syndrome". Nature Genetics. 39 (1): 70–74. doi:10.1038/ng1926. PMID 17143285. S2CID 10222262.
Hatakeyama M, Higashi H (December 2005). "Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis". Cancer Science. 96 (12): 835–843. doi:10.1111/j.1349-7006.2005.00130.x. PMC 11159386. PMID 16367902. S2CID 5721063.
Hatakeyama M (September 2004). "Oncogenic mechanisms of the Helicobacter pylori CagA protein". Nature Reviews. Cancer. 4 (9): 688–694. doi:10.1038/nrc1433. PMID 15343275. S2CID 1218835.
Pumphrey NJ, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, et al. (April 1999). "Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31". FEBS Letters. 450 (1–2): 77–83. Bibcode:1999FEBSL.450...77P. doi:10.1016/S0014-5793(99)00446-9. PMID 10350061. S2CID 31471121.
Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M (April 2001). "Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction". Oncogene. 20 (16): 1929–1938. doi:10.1038/sj.onc.1204290. PMID 11360177. S2CID 25346661.
Crouin C, Arnaud M, Gesbert F, Camonis J, Bertoglio J (April 2001). "A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners". FEBS Letters. 495 (3): 148–153. Bibcode:2001FEBSL.495..148C. doi:10.1016/S0014-5793(01)02373-0. PMID 11334882. S2CID 24499468.
Zhang S, Mantel C, Broxmeyer HE (March 1999). "Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells". Journal of Leukocyte Biology. 65 (3): 372–380. doi:10.1002/jlb.65.3.372. PMID 10080542. S2CID 38211235.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

Wolf I, Jenkins BJ, Liu Y, Seiffert M, Custodio JM, Young P, et al. (January 2002). "Gab3, a New DOS/Gab Family Member, Facilitates Macrophage Differentiation". Molecular and Cellular Biology. 22 (1): 231–244. doi:10.1128/MCB.22.1.231-244.2002. ISSN 0270-7306. PMC 134230. PMID 11739737. and associates transiently with the SH2 domain-containing proteins p85 and SHP2

PTPN11 (English Wikipedia)

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

books.google.com (Global: 3rd place; English: 3rd place)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 630th place; English: 326th place)